Since HELLS is expressed in many tumors and plays a relevant role in the transcription and genomic stability of cancers, its pharmacological inhibition may represent a promising therapeutic strategy in lymphomas and in other human neoplasms. The gene discussed is HELLS; the disease is lymphoma.